NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Vaccines



Biovest's CEO to Discuss Pending Milestones for its Anti-Cancer Vaccine, BiovaxID(R), on Wall Street TV and at Las Vegas Small Cap Investment Conference



May 7th, 2008

Biovest International, Inc. (OTCBB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), announced that its Chairman and CEO, Dr. Steven Arikian, is scheduled to be interviewed on the "3 Minute Press Show," an internet financial news program hosted by Tracee Tolentino and featured on Wall Street TV. The broadcast will air on Friday, April 25, 2008 and can be accessed at: http://tv.wallst.net

Additionally, Biovest announced that Dr. Arikian is scheduled to present at the Big Dog IV Small Cap Conference to be hosted at the Wynn Hotel in Las Vegas on Thursday, May 1, 2008 at 9:00 a.m.

Dr. Arikian commented, "Based on our...


Source: Vaccine Weekly (2008-05-07)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login